These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 32857993)
1. Pharmacology and therapeutic potential of venom peptides. Robinson SD; Vetter I Biochem Pharmacol; 2020 Nov; 181():114207. PubMed ID: 32857993 [No Abstract] [Full Text] [Related]
2. Peptide therapeutics from venom: Current status and potential. Pennington MW; Czerwinski A; Norton RS Bioorg Med Chem; 2018 Jun; 26(10):2738-2758. PubMed ID: 28988749 [TBL] [Abstract][Full Text] [Related]
3. Animal toxins - Nature's evolutionary-refined toolkit for basic research and drug discovery. Herzig V; Cristofori-Armstrong B; Israel MR; Nixon SA; Vetter I; King GF Biochem Pharmacol; 2020 Nov; 181():114096. PubMed ID: 32535105 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular-Active Venom Toxins: An Overview. Rebello Horta CC; Chatzaki M; Rezende BA; Magalhães Bde F; Duarte CG; Felicori LF; Ribeiro Oliveira-Mendes BB; do Carmo AO; Chávez-Olórtegui C; Kalapothakis E Curr Med Chem; 2016; 23(6):603-22. PubMed ID: 26812904 [TBL] [Abstract][Full Text] [Related]
5. Venom Peptides: Improving Specificity in Cancer Therapy. Mahadevappa R; Ma R; Kwok HF Trends Cancer; 2017 Sep; 3(9):611-614. PubMed ID: 28867164 [TBL] [Abstract][Full Text] [Related]
6. Venom peptides as therapeutics: advances, challenges and the future of venom-peptide discovery. Robinson SD; Undheim EAB; Ueberheide B; King GF Expert Rev Proteomics; 2017 Oct; 14(10):931-939. PubMed ID: 28879805 [TBL] [Abstract][Full Text] [Related]
7. Venoms as a platform for human drugs: translating toxins into therapeutics. King GF Expert Opin Biol Ther; 2011 Nov; 11(11):1469-84. PubMed ID: 21939428 [TBL] [Abstract][Full Text] [Related]
8. [Venoms and medical research]. Ducancel F Biol Aujourdhui; 2016; 210(2):89-99. PubMed ID: 27687600 [TBL] [Abstract][Full Text] [Related]
9. Advances in venom peptide drug discovery: where are we at and where are we heading? Smallwood TB; Clark RJ Expert Opin Drug Discov; 2021 Oct; 16(10):1163-1173. PubMed ID: 33914674 [No Abstract] [Full Text] [Related]
10. Venom peptides as pharmacological tools and therapeutics for diabetes. Robinson SD; Safavi-Hemami H Neuropharmacology; 2017 Dec; 127():79-86. PubMed ID: 28689026 [TBL] [Abstract][Full Text] [Related]
11. Breakthroughs in Venom Peptide Screening Methods to Advance Future Drug Discovery. Napolitano T; Holford M Protein Pept Lett; 2018; 25(12):1137-1148. PubMed ID: 30381057 [TBL] [Abstract][Full Text] [Related]
16. Constellation pharmacology: a new paradigm for drug discovery. Teichert RW; Schmidt EW; Olivera BM Annu Rev Pharmacol Toxicol; 2015; 55():573-89. PubMed ID: 25562646 [TBL] [Abstract][Full Text] [Related]
17. Harnessing the knowledge of animal toxins to generate drugs. Zambelli VO; Pasqualoto KF; Picolo G; Chudzinski-Tavassi AM; Cury Y Pharmacol Res; 2016 Oct; 112():30-36. PubMed ID: 26826284 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic peptides: Historical perspectives, current development trends, and future directions. Lau JL; Dunn MK Bioorg Med Chem; 2018 Jun; 26(10):2700-2707. PubMed ID: 28720325 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticles Functionalized with Venom-Derived Peptides and Toxins for Pharmaceutical Applications. Dos Santos AP; de Araújo TG; Rádis-Baptista G Curr Pharm Biotechnol; 2020; 21(2):97-109. PubMed ID: 31223083 [TBL] [Abstract][Full Text] [Related]
20. Centipede venoms as a source of drug leads. Undheim EA; Jenner RA; King GF Expert Opin Drug Discov; 2016 Dec; 11(12):1139-1149. PubMed ID: 27611363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]